Richard Greil

Richard Greil

UNVERIFIED PROFILE

Are you Richard Greil?   Register this Author

Register author
Richard Greil

Richard Greil

Publications by authors named "Richard Greil"

Are you Richard Greil?   Register this Author

100Publications

1044Reads

22Profile Views

IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?

Br J Haematol 2020 Aug 17;190(3):314-317. Epub 2020 May 17.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16710DOI Listing
August 2020

RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia.

Leukemia 2020 Jul 30. Epub 2020 Jul 30.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0995-6DOI Listing
July 2020

Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial.

J Clin Med 2020 Jun 1;9(6). Epub 2020 Jun 1.

Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Department of Internal Medicine III with Haematology, Salzburg Cancer Research Institute, Oncologic Center Salzburg, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm9061663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355487PMC
June 2020

Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.

J Clin Oncol 2020 Jun 23:JCO1903160. Epub 2020 Jun 23.

German Hodgkin Study Group, University of Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.03160DOI Listing
June 2020

RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia.

Cancers (Basel) 2020 May 5;12(5). Epub 2020 May 5.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Müllner Hauptstrasse 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12051159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280959PMC
May 2020

Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence.

Int J Mol Sci 2020 Apr 19;21(8). Epub 2020 Apr 19.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21082856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215892PMC
April 2020

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

N Engl J Med 2020 02 11;382(7):597-609. Epub 2019 Dec 11.

From M.D. Anderson Cancer Center, Houston (R.K.M., G.H.); Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (S. Loi); the Royal Marsden NHS Foundation Trust, London (A.O.), and Edinburgh Cancer Research Centre, Edinburgh (D.C.) - both in the United Kingdom; Winship Cancer Institute, Atlanta (E.P.); Sarah Cannon Research Institute/Tennessee Oncology-Nashville (E.H.) and Vanderbilt University Medical Center (V.A.), Nashville; University of California, Los Angeles, Medical Center-Jonsson Comprehensive Cancer Center, Los Angeles (S.A.H., D.S.), and Stanford Comprehensive Cancer Institute, Palo Alto (M.P.) - both in California; Dana-Farber Cancer Institute, Boston (N.U.L., I.K., E.P.W.); University of Colorado Cancer Center, Aurora (V.B.); Duke Cancer Institute, Durham (C.A.), and University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill (L.A.C.) - both in North Carolina; University Health Network, Princess Margaret Cancer Centre, Toronto (P.L.B.), and British Columbia Cancer, Vancouver (K.G.) - both in Canada; Hospital Universitario Vall D'Hebron, Barcelona (M.O.); Sygehus Lillebaelt-Vejle Sygehus, Vejle, Denmark (E.J.); Centre Léon Bérard, Lyon, France (T.B.); Rambam Health Care Campus, Haifa, Israel (S.S.S.); Universitaetsklinikum Hamburg-Eppendorf, Hamburg (V.M.), and German Breast Group, Neu-Isenburg (S. Loibl) - both in Germany; Hospital Cuf Descobertas R. Mário Botas, Lisbon, Portugal (S.B.); Cliniques Universitaires Saint-Luc, Brussels (F.P.D.); Third Medical Department, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, and Cancer Cluster Salzburg, Salzburg, Austria (R.G.); Istituto Europeo di Oncologia, IRCCS, University of Milan, Milan (G.C.); and Seattle Genetics, Bothell, WA (M.C.P.-W., L.W., W.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1914609DOI Listing
February 2020

Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer.

Oncol Lett 2020 Feb 9;19(2):1551-1558. Epub 2019 Dec 9.

IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, A-5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2019.11192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956108PMC
February 2020

Structure-Guided Identification of Black Cohosh () Triterpenoids with In Vitro Activity against Multiple Myeloma.

Molecules 2020 Feb 11;25(4). Epub 2020 Feb 11.

Department of Pharmaceutical Biology, Kiel University, Gutenbergstraße 76, 24118 Kiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules25040766DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070908PMC
February 2020

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia.

Leukemia 2020 Feb 21. Epub 2020 Feb 21.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0759-3DOI Listing
February 2020

Transcatheter aortic valve implantation in a patient with suspected hereditary von Willebrand disease and severe gastrointestinal bleeding - a case report.

Scott Med J 2019 Nov 19;64(4):142-147. Epub 2019 Jul 19.

Head of Department and Professor of Medicine, Department of Internal Medicine II, Department of Cardiology, Paracelsus Medical University of Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0036933019862155DOI Listing
November 2019

B-cell-specific IRF4 deletion accelerates chronic lymphocytic leukemia development by enhanced tumor immune evasion.

Blood 2019 11;134(20):1717-1729

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019000973DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6895374PMC
November 2019

Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia.

Ann Hematol 2019 Nov 18;98(11):2569-2578. Epub 2019 Oct 18.

Internal Medicine V (Hematology & Oncology), Medical University of Innsbruck, Anichstr. 35, 6020, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-019-03797-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6848044PMC
November 2019

Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.

Wien Klin Wochenschr 2019 Oct 16. Epub 2019 Oct 16.

Department of Internal Medicine I/Clinical Division of Medical Oncology, Medical University Vienna-General Hospital, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-019-01556-1DOI Listing
October 2019

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.

J Clin Med 2019 Oct 25;8(11). Epub 2019 Oct 25.

rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Paracelsus Medical University, 5071 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8111791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912559PMC
October 2019

Lignans and sesquiterpene lactones from Hypochaeris radicata subsp. neapolitana (Asteraceae, Cichorieae).

Phytochemistry 2019 Sep 13;165:112047. Epub 2019 Jun 13.

Pharmazeutisches Institut, Abteilung Pharmazeutische Biologie, Christian-Albrechts-Universität zu Kiel, Gutenbergstraße 76, 24118, Kiel, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phytochem.2019.05.020DOI Listing
September 2019

Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.

Anticancer Res 2019 Sep;39(9):4589-4596

Third Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumatology, Oncology Centre, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13638DOI Listing
September 2019

Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.

Therap Adv Gastroenterol 2019 23;12:1756284819877635. Epub 2019 Sep 23.

Department of Radiation Oncology, Kantonsspital St. Gallen, Rorschacher Strasse 95, St. Gallen, 9007, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756284819877635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759720PMC
September 2019

Mouse models to decipher anti-tumor immunity.

Oncotarget 2019 Aug 20;10(49):5005-5006. Epub 2019 Aug 20.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria; Cancer Cluster Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707950PMC
August 2019

Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade.

J Clin Med 2019 Jul 10;8(7). Epub 2019 Jul 10.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8071014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678702PMC
July 2019

Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.

Clin Colorectal Cancer 2019 06 11;18(2):159-166.e3. Epub 2019 Apr 11.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology, and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute, Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15330028183055
Publisher Site
http://dx.doi.org/10.1016/j.clcc.2019.04.003DOI Listing
June 2019

Investigating epigenetic effects of activation-induced deaminase in chronic lymphocytic leukemia.

PLoS One 2018 20;13(12):e0208753. Epub 2018 Dec 20.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria, Cancer Cluster Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0208753PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301619PMC
May 2019

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.

Eur J Haematol 2019 May 28;102(5):437-441. Epub 2019 Feb 28.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster Salzburg, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849823PMC
May 2019

DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer.

Theranostics 2018 11;8(8):2278-2288. Epub 2018 Mar 11.

III rd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (CCCIT); Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.23544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928889PMC
April 2019

Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development.

Leukemia 2019 04 27;33(4):957-968. Epub 2018 Sep 27.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-018-0260-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477797PMC
April 2019

Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.

PLoS One 2018 9;13(11):e0206688. Epub 2018 Nov 9.

IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0206688PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226156PMC
April 2019

BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation.

Clin Cancer Res 2019 03 28;25(6):1901-1912. Epub 2018 Nov 28.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1548DOI Listing
March 2019

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer.

Int J Mol Sci 2019 Mar 5;20(5). Epub 2019 Mar 5.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20051115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429068PMC
March 2019

Next Generation Sequencing in AML-On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?

Cancers (Basel) 2019 Feb 21;11(2). Epub 2019 Feb 21.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR), Salzburg 5020, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11020252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406956PMC
February 2019

Cytotoxic Properties of Damiana () Extracts and Constituents and A Validated Quantitative UHPLC-DAD Assay.

Molecules 2019 Feb 28;24(5). Epub 2019 Feb 28.

Department of Pharmaceutical Biology, Kiel University, Gutenbergstraße 76, 24118 Kiel, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/molecules24050855DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429218PMC
February 2019

Plitidepsin: a potential new treatment for relapsed/refractory multiple myeloma.

Future Oncol 2019 Jan 16;15(2):109-120. Epub 2018 Aug 16.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology & Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory of Immunological & Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria, Cancer Cluster Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0492DOI Listing
January 2019

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).

Breast Cancer Res 2019 01 31;21(1):19. Epub 2019 Jan 31.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13058-018-1091-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357474PMC
January 2019

Extensive Leptomeningeal Intracranial and Spinal Metastases in a Patient with a Supratentorial Glioblastoma Multiforme, IDH-Wildtype.

World Neurosurg 2018 Dec 22;120:442-447. Epub 2018 Sep 22.

Department of Neurosurgery, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2018.09.082DOI Listing
December 2018

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial.

Cancer Med 2018 12 10;7(12):5962-5972. Epub 2018 Nov 10.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.1851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308077PMC
December 2018

Remission maintenance treatment options in chronic lymphocytic leukemia.

Cancer Treat Rev 2018 Nov 10;70:56-66. Epub 2018 Aug 10.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Austria; Salzburg Cancer Research Institute and Cancer Cluster Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2018.08.003DOI Listing
November 2018

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

BMC Cancer 2018 Nov 6;18(1):1074. Epub 2018 Nov 6.

IIIrd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
https://bmccancer.biomedcentral.com/articles/10.1186/s12885-
Publisher Site
http://dx.doi.org/10.1186/s12885-018-4979-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220453PMC
November 2018

ASCO 2018 highlights: metastatic breast cancer.

Memo 2018 20;11(4):276-279. Epub 2018 Nov 20.

1IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-018-0450-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280779PMC
November 2018

Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.

J Clin Oncol 2018 09 10;36(25):2603-2611. Epub 2018 Jul 10.

Stephanie Sasse, Helen Goergen, Annette Plütschow, Boris Böll, Dennis A. Eichenauer, Michael Fuchs, Karolin Behringer, Christian Baues, Andreas Engert, Peter Borchmann, and Bastian von Tresckow, University Hospital of Cologne, Cologne; Max S. Topp, University Hospital of Würzburg, Würzburg; Julia Meissner, University of Heidelberg, Heidelberg; Andreas Neubauer, Philipps University, Marburg, Germany; Joseé M. Zijlstra, VU University Medical Center, Amsterdam, the Netherlands; Richard Greil, Paracelsus Medical University Salzburg, Salzburg Cancer Research Institute and Arbeitsgemeinschaft Medikamentöse Tumortherapie, Salzburg, Austria; and Jana Markova, Charles University in Prague and Faculty Hospital Kralovske Vinohrady, Prague, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.7192DOI Listing
September 2018

Risks and chances of aberrant DNA repair in cancer.

Oncoscience 2018 Sep 22;5(9-10):256-257. Epub 2018 Aug 22.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria; Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Cancer Cluster, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncoscience.459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231446PMC
September 2018

Cure in metastatic breast cancer.

Memo 2018 17;11(3):172-179. Epub 2018 Aug 17.

1IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-018-0426-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132799PMC
August 2018

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis.

Memo 2018 21;11(3):208-212. Epub 2018 Aug 21.

1IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-018-0433-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132796PMC
August 2018

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group.

Eur J Cancer 2018 04 20;93:69-78. Epub 2018 Mar 20.

IIIrd Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria; Salzburg Cancer Research Institute, Salzburg, Austria; Cancer Cluster Salzburg, Salzburg, Austria. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183007
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.01.064DOI Listing
April 2018

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations.

Oncotarget 2018 Apr 17;9(29):20928-20940. Epub 2018 Apr 17.

IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelsus Medical University, A-5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.25037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945535PMC
April 2018

Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia.

Mol Cancer Res 2018 03 8;16(3):428-438. Epub 2017 Dec 8.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory for Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Austria.

View Article

Download full-text PDF

Source
http://mcr.aacrjournals.org/lookup/doi/10.1158/1541-7786.MCR
Publisher Site
http://dx.doi.org/10.1158/1541-7786.MCR-17-0373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837005PMC
March 2018

Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.

Blood 2018 03 19;131(12):1337-1349. Epub 2018 Jan 19.

Third Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-08-802462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865232PMC
March 2018

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia.

Wien Klin Wochenschr 2018 Feb 30;130(3-4):115-125. Epub 2018 Jan 30.

Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Disease, Rheumatology, Oncologic Center, Laboratory of Immunological and Molecular Cancer Research, Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00508-018-1315-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816094PMC
February 2018

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).

BMC Cancer 2018 01 3;18(1):11. Epub 2018 Jan 3.

IIIrd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Paracelsus Medical University, 5020, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3955-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753540PMC
January 2018

Antiangiogenic therapy in breast cancer.

Memo 2017 6;10(4):194-201. Epub 2017 Nov 6.

IIIrd Medical Department with Hematology and Medical Oncology, Oncologic Center, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0362-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725520PMC
November 2017

ASCO-update: gastrointestinal tumors.

Memo 2017 13;10(4):240-243. Epub 2017 Nov 13.

IIIrd Medical Department of Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectious Disease, Salzburg Cancer Research Institute (SCRI), Paracelsus Medical University, Muellner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0366-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725513PMC
November 2017

Update on squamous cell carcinoma of the head and neck: ASCO annual meeting 2017.

Memo 2017 20;10(4):220-223. Epub 2017 Oct 20.

Third Medical Department with Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Müllner Hauptstraße 48, 5020 Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12254-017-0358-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725515PMC
October 2017

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Oncoimmunology 2017 21;7(1):e1371399. Epub 2017 Sep 21.

Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1371399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739567PMC
September 2017